Related Experiment Video
Updated: Jun 28, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Dual role of signaling pathways in myeloma requires cell type-specific targeting of ligand-receptor interactions
Pablo Hernandez-Lopez1, Tushara Vijaykumar1, Praveen Anand1,2,3
1Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA.
Abstract:
Although most patients with multiple myeloma respond to treatment initially, therapy resistance develops almost invariably, and only a subset of patients show durable responses to immunomodulatory therapies. Although the immune microenvironment has been extensively studied in patients with myeloma, its composition is currently not used as prognostic markers in clinical routine. We hypothesized that the outcome of immune signaling pathway engagement can be highly variable, depending on which 2 cellular populations participate in this interaction. This would have important prognostic and therapeutic implications, suggesting that it is crucial for immune pathways to be targeted in a specific cellular context. To test this hypothesis, we investigated a cohort of 25 patients with newly diagnosed multiple myeloma. We examined the complex regulatory networks within the immune compartment and their impact on disease progression. Analysis of immune cell composition and expression profiles revealed significant differences in the B-cell compartment associated with treatment response. Transcriptional states in patients with short time to progression demonstrated an enrichment of pathways promoting B-cell differentiation and inflammatory responses, which may indicate immune dysfunction. Importantly, the analysis of molecular interactions within the immune microenvironment highlights the dual role of signaling pathways, which can either be associated with good or poor prognosis depending on the cell types involved. Our findings therefore argue that therapeutic strategies targeting ligand-receptor interactions should take into consideration the composition of the microenvironment and the specific cell types involved in molecular interactions.
Insights
Immune cell interactions in multiple myeloma impact treatment response. Targeting specific cellular contexts within the immune microenvironment is crucial for effective therapies against this blood cancer.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Multiple myeloma (MM) patients often develop therapy resistance, limiting durable responses to immunomodulatory treatments.
- The immune microenvironment's composition is not routinely used for prognosis in MM.
- Immune signaling pathway outcomes may vary based on interacting cell types, suggesting context-dependent prognostic and therapeutic implications.
Purpose of the Study:
- To investigate the prognostic and therapeutic implications of immune signaling pathways in multiple myeloma.
- To explore how cellular context influences immune pathway engagement in MM.
- To identify potential prognostic markers within the immune microenvironment.
Main Methods:
- Analysis of immune cell composition and gene expression profiles in a cohort of 25 newly diagnosed multiple myeloma patients.
- Examination of regulatory networks within the immune compartment.
- Investigation of molecular interactions within the immune microenvironment.
Main Results:
- Significant differences in the B-cell compartment were associated with treatment response in MM patients.
- Patients with a short time to progression showed enrichment of pathways related to B-cell differentiation and inflammation, suggesting immune dysfunction.
- Molecular interactions within the immune microenvironment demonstrated a dual role for signaling pathways, correlating with either good or poor prognosis based on cell types.
Conclusions:
- The cellular context of immune interactions is critical for determining prognostic and therapeutic outcomes in multiple myeloma.
- Targeting ligand-receptor interactions requires consideration of the specific microenvironment composition and involved cell types.
- Immune microenvironment profiling may offer novel prognostic markers and guide personalized therapeutic strategies in multiple myeloma.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Amplifying Signals via Enzymatic Cascade
Signal Transduction: Overview
Typically, signal transduction involves three...

